US FDA Final Rule Categorizes the Safety and Effectiveness of 28 Hand Sanitizer Active Ingredients

5/13/2019 10:55:35 AM

(MENAFN- Online PR News) FDA releases final rule on safety and effectiveness for 28 ingredients used in consumer hand sanitizers.
Online PR News 13-May-2019 Geneva, Switzerland The US Food and Drug Administration (FDA) has published a final rule on the safety and effectiveness of 28 active ingredients used in consumer hand sanitizers.

These 28 active ingredients are considered Category II - not generally recognized as safe and effective or misbranded. They include:

1. Benzethonium chloride

2. Chloroxylenol

3. Chlorhexidine gluconate

4. Cloflucarban

5. Fluorosalan

6. Hexachlorophene

7. Hexylresorcinol

8. Iodine complex (ammonium ether sulfate and polyoxyethylene sorbitan monolaurate)

9. Iodine complex (phosphate ester of alkylaryloxy polyethylene glycol)

10. Methylbenzethonium chloride

11. Nonylphenoxypoly (ethyleneoxy) ethanoliodine

12. Phenol (equal to or less than 1.5 percent or greater than 1.5 percent)

13. Poloxamer iodine complex

14. Povidone-iodine 5 to 10 percent

15. Secondary amyltricresols

16. Sodium oxychlorosene

17. Tribromsalan

18. Triclocarban

19. Triclosan

20. Triple dye

21. Undecoylium chloride iodine complex

22. Polyhexamethylene biguanide

23. Benzalkonium cetyl phosphate

24. Cetylpyridinium chloride

25. Salicylic acid

26. Sodium hypochlorite

27. Tea tree oil

28. Combination of potassium vegetable oil solution, phosphate sequestering agent, and triethanolamine

The FDA believes the nonmonograph status of these ingredients means they affect less than 3% of consumer antiseptic rubs, otherwise known as hand sanitizers, currently in the marketplace.

The FDA has also deferred making a final rule on the following three substances to allow the development and submission of new safety and effectiveness data. They are:

• Ethanol

• Isopropyl alcohol

• Benzalkonium chloride

In addition, the statistical analysis used for efficacy has been updated. It now requires bacterial log reduction studies to continue as a demonstration that an active ingredient is effective. The rules also require substances to participate in a randomized three-arm study containing:

1. Test

2. Active control

3. Negative control

The statistical analysis related to the log reduction criteria for classifying consumer antiseptic rub active ingredients is also to be considered Generally Recognized as Effective (GRAE).

The FDA has also updated the following requirements for testing efficacy:

• The test product should be non-inferior to an FDA-approved antiseptic rub as active control with a 0.5 margin (log10 scale)

• Requiring the test product should be superior to the negative control by a margin of 1.5 (log10 scale)

• A minimum sample size of 100 subjects per treatment arm

• Two adequate and well-controlled clinical simulation pivotal studies for the consumer antiseptic rub indication at two separate independent laboratory facilities by independent principal investigators must be conducted

Stakeholders are now advised to make sure their products comply with the latest regulations before offering hand sanitizers onto the market in the US.

SGS Cosmetics & Personal Care Testing Services

SGS provides testing, inspection, auditing and consulting services to manufacturers, distributors and importers to ensure a high level of product quality in every area. A global network of state-of-the-art laboratories offer custom-made solutions for chemical, biophysical, microbiological, stability and biological aspects. Learn more about SGS's Cosmetics & Personal Care Testing Services. (www.sgs.com/en/consumer-goods-retail/cosmetics-personal-care-and-household/cosmetics-and-personal-care/testing)

For further information contact:

Joseph Scognamiglio

Technical Manager

Tel: +1 973-461-7937

Email:

About SGS

SGS is the world's leading inspection, verification, testing and certification company. SGS is recognized as the global benchmark for quality and integrity. With more than 97,000 employees, SGS operates a network of over 2,600 offices and laboratories around the world.

MENAFN1305201900703081ID1098516555

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.